Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-23-023965

Chief Development Officer sold 1,527 shares at an average $1.57 ($2,396)

  • Chief Development Officer acquired 5,054 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pestano Gary Anthony · Chief Development Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-08 Exercise or conversion : show line 1 in the form +5,054 100,987 D
2023-05-09 Sale : show line 2 in the form −1,101 $1.57 $1,725 99,886 D
2023-05-10 Sale : show line 3 in the form −426 $1.58 $671 99,460 D
Open-market sales · 1,527 sh · avg $1.57 · $2,396

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-05-08 Exercise or conversion : show line 4 in the form Restricted Stock Units −1,378 15,161 D
2023-05-08 Exercise or conversion : show line 5 in the form Restricted Stock Units −3,676 3,675 D
Loading xslF345X04/form4.xml…